相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emulsions loaded with dihydromyricetin enhance its transport through Caco-2 monolayer and improve anti-diabetic effect in insulin resistant HepG2 cell
Lei Chen et al.
JOURNAL OF FUNCTIONAL FOODS (2020)
Chlorogenic acid and caffeic acid from Sonchus oleraceus Linn synergistically attenuate insulin resistance and modulate glucose uptake in HepG2 cells
Lei Chen et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress
Zhi Geng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Fenofibrate ameliorates neural, mechanical, chemical, and electrical alterations in the murine model of heart failure
N. Dhyani et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2019)
Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis
Sarah R. Anthony et al.
CLINICAL SCIENCE (2019)
Mitochondrial membrane transporters and metabolic switch in heart failure
Vikas Kumar et al.
HEART FAILURE REVIEWS (2019)
Gallic Acid Suppresses Cardiac Hypertrophic Remodeling and Heart Failure
Xiao Yan et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
Zhenzhen Li et al.
FRONTIERS IN PHARMACOLOGY (2019)
Decreased ATP production and myocardial contractile reserve in metabolic heart disease
Ivan Luptak et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Gallic acid improves cardiac dysfunction and fibrosis in pressure overload-induced heart failure
Li Jin et al.
SCIENTIFIC REPORTS (2018)
Magnolol Alleviates Inflammatory Responses and Lipid Accumulation by AMP-Activated Protein Kinase-Dependent Peroxisome Proliferator-Activated Receptor α Activation
Ye Tian et al.
FRONTIERS IN IMMUNOLOGY (2018)
Developmental regulation and localization of carnitine palmitoyltransferases (CPTs) in rat brain
Jennifer N. Jemberg et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Polyphenol rich ethanolic extract from Boerhavia diffusa L. mitigates angiotensin II induced cardiac hypertrophy and fibrosis in rats
A. Prathapan et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
The role of autophagy in cardiac hypertrophy
Lanfang Li et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2016)
NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy
Zhongbao Yue et al.
EXPERIMENTAL CELL RESEARCH (2016)
STAT3 Suppression Is Involved in the Protective Effect of SIRT6 Against Cardiomyocyte Hypertrophy
Xiaoying Zhang et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity
Yuhee Ryu et al.
SCIENTIFIC REPORTS (2016)
Downregulation of adipose triglyceride lipase promotes cardiomyocyte hypertrophy by triggering the accumulation of ceramides
Hui Gao et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2015)
The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1
Xiao-Jun Feng et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction
Marta Toral et al.
CLINICAL SCIENCE (2015)
Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate
Ping Li et al.
MOLECULAR MEDICINE REPORTS (2015)
Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-?B-dependent transcriptional activity
Shan-Shan Yu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Fenofibrate ameliorates cardiac hypertrophy by activation of peroxisome proliferator-activated receptor-α partly via preventing p65-NFκB binding to NFATc4
Jian Zou et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
AMPK: a nutrient and energy sensor that maintains energy homeostasis
D. Grahame Hardie et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Age exacerbates chronic catecholamine-induced impairments in contractile reserve in the rat
John T. Liles et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway
Rongsen Meng et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Molecular targets and regulators of cardiac hypertrophy
Rohini Agrawal et al.
PHARMACOLOGICAL RESEARCH (2010)
Assembly of the oxidative phosphorylation system in humans: What we have learned by studying its defects
Erika Fernandez-Vizarra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Energy metabolism in heart failure and remodelling
Joanne S. Ingwall
CARDIOVASCULAR RESEARCH (2009)
Effect of Pretreatment With Coenzyme Q10 on Isoproterenol-Induced Cardiotoxicity and Cardiac Hypertrophy in Rats
Arvindkumar E. Ghule et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2009)
Mechanisms of disease: Cardiac plasticity
Joseph A. Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The repeatability of fish biomass and size distribution estimates obtained by hydroacoustic surveys using various sampling strategies and statistical analyses
Jean Guillard et al.
INTERNATIONAL REVIEW OF HYDROBIOLOGY (2007)
Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats
Si-Gui Zhou et al.
JOURNAL OF PROTEOME RESEARCH (2006)
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation
B Guigas et al.
DIABETES (2006)
Altered cardiac expression of peroxisome proliferator-activated receptor-isoforms in patients with hypertensive heart disease
MJ Goikoetxea et al.
CARDIOVASCULAR RESEARCH (2006)
Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-α activators
SH Han et al.
HYPERTENSION (2005)
Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy
CG Proud
CARDIOVASCULAR RESEARCH (2004)
Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative α2 subunit of AMP-activated protein kinase
YQ Xing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy
MH Gollob et al.
CIRCULATION (2001)
Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy
R Tian et al.
CIRCULATION (2001)
分享论文
